Today: 3 March 2026
Subscribe
Browse Category

Stock Market 6 October 2025

Spruce Biosciences Skyrockets on FDA Breakthrough – Will SPRB’s Rally Last or Fade?

Spruce Biosciences Skyrockets on FDA Breakthrough – Will SPRB’s Rally Last or Fade?

Spruce Biosciences shares jumped over 250% intraday on Oct. 6, 2025, after the FDA granted Breakthrough Therapy Designation to its lead drug, tralesinidase alfa, for Sanfilippo Syndrome Type B. The stock rose from around $9 to $31. Spruce regained its Nasdaq listing in September following a reverse split. The company reported $16.4 million in cash as of June 30 and remains unprofitable.
6 October 2025
··
Figma Stock’s Post-IPO Rollercoaster: From $68 Billion Debut to Wild Drops – What’s Next for FIG?

Figma Stock’s Post-IPO Rollercoaster: From $68 Billion Debut to Wild Drops – What’s Next for FIG?

Figma shares soared over 250% on debut in July 2025, closing above $115 before plunging more than 50% by October, trading in the mid-$50s. Its first earnings report beat estimates but shares fell 13% as growth guidance disappointed. Four new products launched in 2025, including AI tool Figma Make. Most analysts rate FIG a “Hold,” with a $67 median price target amid concerns over slowing growth.
6 October 2025
·
Sanmina Stock Skyrockets on AMD-OpenAI AI Deal – Key Financials, Trends & Outlook 2025

Sanmina Stock Skyrockets on AMD-OpenAI AI Deal – Key Financials, Trends & Outlook 2025

Sanmina shares jumped over 22% to a record high on October 6 after AMD named it as a key manufacturing partner in a major AI chip deal with OpenAI. The company is acquiring ZT Systems’ data center unit from AMD for up to $3 billion, aiming to double revenue. Sanmina’s fiscal Q3 results beat estimates, with $2.04 billion in revenue and $1.53 EPS. The stock is up about 70% year-over-year.
6 October 2025
···
Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Comerica shares jumped as much as 15% to $81 on October 6, 2025, after Fifth Third Bancorp announced a $10.9 billion all-stock acquisition at a 20% premium. Fifth Third stock dipped 0.3%. The deal would create the ninth-largest U.S. bank with $288 billion in assets. Analysts cited regulatory tailwinds and scale benefits but warned of integration risks.
6 October 2025
···
Broadcom’s $10B AI Chip Deal Ignites Stock Surge – What’s Powering This Tech Giant’s Boom

Broadcom’s $10B AI Chip Deal Ignites Stock Surge – What’s Powering This Tech Giant’s Boom

Broadcom reported record fiscal Q3 2025 revenue of $16 billion, up 22% year-over-year, driven by a 63% surge in AI chip sales. Shares recently traded near $333 after a 10-for-1 split, pushing market cap to $1.6 trillion. The company disclosed a $10 billion custom AI chip order, widely believed to be from OpenAI. CEO Hock Tan extended his contract by five years as Broadcom expands its AI and software business.
6 October 2025
·
AI Ignites a Nuclear Renaissance: How Tech Titans, Policy Shifts and New Reactors Are Powering the Next Energy Revolution

Nano Nuclear’s Stock Explodes: Could Micro‑Reactors Spark a New Energy Revolution? – NNE Company Report (Oct 2025)

Nano Nuclear Energy Inc. (NASDAQ: NNE) closed at $51.57 on Oct. 6, up nearly 16% with 4 million shares traded. The company’s market cap stands at $2.17 billion, with a price-to-book ratio of 8.2 and no revenue. NNE joined major S&P indexes in late September and recently signed a $1.25 million Air Force contract for its KRONOS micro‑modular reactor. Short interest is about 18% of the float.
6 October 2025
···
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer Stock Soars After Trump’s Drug Deal and Obesity Bet – Is This the Start of a Comeback?

Pfizer shares surged 15% in late September 2025, jumping from $23.60 to $27.20 after a drug-pricing deal with the Trump administration slashed Medicaid prices and a $7.3 billion acquisition of obesity-drug maker Metsera. The stock hovered near $27–$28 as of Oct. 6, near its 52-week high. Pfizer’s dividend yield rose above 7% after earlier declines. Q2 revenue climbed 10% year-over-year to $14.7 billion.
6 October 2025
·
Robinhood (HOOD) Explodes 12% to Fresh Highs — Here’s What Lit the Fuse and What Comes Next (Sept 29, 2025)

Robinhood’s Stock Skyrockets 200% – S&P 500 Debut, Crypto Push & Outage Drama in 2025

Robinhood Markets shares have surged over 200% in 2025, trading near $147 and pushing its market cap above $100 billion after S&P 500 inclusion. Q2 revenue jumped 45% to $989 million and net income doubled. A major outage on Oct. 6 briefly halted trading and sent shares down 1.3%. Robinhood recently began offering preferred stock trading and expanded its crypto lineup amid rising competition.
6 October 2025
···
AST SpaceMobile Stock Skyrockets on Satellite Breakthroughs and Big-Name Backing

AST SpaceMobile (ASTS) Skyrockets on Satellite Breakthroughs – SpaceX & AT&T Partnerships Fuel Rally

AST SpaceMobile shares soared to record highs, closing near $66.16 on Oct. 2 and opening at $67.76 on Oct. 6 after announcing its BlueBird-6 satellite is ready for launch and expanding its partnership with Bell Canada. The company successfully tested direct-to-cell calls from space and plans to deploy up to 60 satellites by 2026. Wall Street remains split on the stock, which is up over 95% year-to-date.
6 October 2025
··
Lithium Americas (LAC) Soars as US Govt Takes 5% Stake – Analysts Weigh In on EV Lithium Boom

Lithium Americas (LAC) Soars on U.S. ‘White Gold’ Stake – Latest News, Stock Rally & Expert Outlook

Lithium Americas secured a $2.26 billion U.S. Department of Energy loan in October 2025 for its Thacker Pass lithium project, with the DOE and GM now holding equity stakes. LAC’s stock more than doubled in 2025, spiking 23% on news of the federal deal. The company remains pre-revenue, reporting a $13 million Q2 net loss but is fully funded for construction. Wall Street consensus rates the stock “Hold” with a $5.10 price target.
6 October 2025
·····
MicroStrategy (MSTR) on Oct. 2 2025: Why the Bitcoin Treasury King Keeps Making Headlines

MicroStrategy (MSTR) Skyrockets as Bitcoin Breaks $120K – Inside the Bold $70B Bitcoin Bet

MicroStrategy shares rose 6% on Oct. 1, 2025, after a favorable crypto tax ruling, trading near $355 as Bitcoin hit record highs above $120,000. The company now holds about 640,000 BTC, worth over $70 billion, and reported a record $10 billion profit in Q2 2025. Analysts expect Q3 net income around $2.9 billion. MicroStrategy rebranded as “Strategy, Inc.” in 2025 to focus on Bitcoin.
6 October 2025
···
Marvell Technology (MRVL) Surges on AI Boom – Latest Stock Price, Major News & 2025 Outlook

Marvell Technology (MRVL) Surges on AI Boom – Latest Stock Price, Major News & 2025 Outlook

Marvell Technology shares trade in the mid-$80s, up 17% year-over-year but down over 20% in 2025 after peaking at $127.48 in January. The stock surged 30% in September on a $5 billion buyback, then dipped after a TD Cowen downgrade before rebounding on AI chip optimism tied to OpenAI and AMD deals. Q2 revenue hit $2.006 billion, up 58% year-over-year, with AI chips now 73% of sales.
6 October 2025
·
Marathon Digital Rides “Uptober” Bitcoin Boom – Stock Soars as Miner Hoards BTC and Eyes Bold 2025 Targets

Marathon Digital Rides “Uptober” Bitcoin Boom – Stock Soars as Miner Hoards BTC and Eyes Bold 2025 Targets

Marathon Digital’s stock jumped nearly 17% in late September 2025 as Bitcoin rallied toward $124,000. The company mined 736 BTC in September, boosting its holdings to 52,850 BTC and maintaining its position as the second-largest corporate holder. Marathon posted $238.5 million in Q2 revenue and raised $950 million for expansion. Its hash rate reached 60.4 EH/s, outpacing key rivals.
6 October 2025
···
IBM Stock Soars on Quantum Breakthrough and AI Revival – Key Updates (Sept 25, 2025)

IBM’s AI Revolution Sends Stock Soaring as Big Blue Takes on Tech Giants

IBM shares trade near $289, close to multi-year highs after a 28% year-to-date surge, pushing market value to $265 billion. The company announced a partnership with AMD and Zyphra to build a major AI supercluster and launched Granite 4.0, an open-source enterprise AI model family. IBM’s aggressive AI and cloud pivot is backed by a $150 billion U.S. investment plan. Analyst sentiment remains mixed.
6 October 2025
····
UiPath’s AI Gold Rush: OpenAI, NVIDIA & Google Deals Ignite PATH’s Stock Rally

UiPath (PATH) Stock Soars on AI Deals and Strong Earnings – 2025 Update

UiPath shares surged 21% intraday on September 30, 2025, after announcing new AI partnerships with OpenAI, Google, NVIDIA, and Snowflake. The company reported a return to GAAP profitability and raised its full-year guidance. Shares now trade near $13, close to their 52-week high. Analysts remain cautious, with an average price target of $13.30 and a consensus “Hold” rating.
6 October 2025
······
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia’s AI Juggernaut: What You Need to Know About NVDA After the $100 Billion OpenAI Deal and Its Record Rally (Oct 2025)

Nvidia closed at $187.62 on Oct 3, with a $4.5 trillion market cap and Q2 FY2026 revenue of $46.7 billion, up 56% year over year. The company committed up to $100 billion in OpenAI for non-voting equity in September. On Oct 6, AMD announced a multi-year deal to supply 6 GW of AI GPUs to OpenAI, with expected revenue exceeding $100 billion over four years. Analysts’ consensus price target for Nvidia stands at $211.
6 October 2025
····
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock Rockets on GLP‑1 Boom and New Approvals: Is LLY the Next Trillion‑Dollar Pharma Titan?

Eli Lilly stock opened at $840.46 on Oct. 6, 2025, after a 9% surge the previous week, with a market cap near $795 billion and P/E ratio around 55. Q2 revenue rose 38% to $15.56 billion, led by Mounjaro and Zepbound, and Lilly raised 2025 guidance to $60–62 billion revenue. The company announced over $1 billion investment in India manufacturing and received European approval for Kisunla in early Alzheimer’s.
6 October 2025
·
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD shares closed at $164.67 on October 6, 2025, valuing the company near $267 billion. The stock jumped about 30% year-to-date after a 2024 slump. AMD announced a multi-year deal to supply AI chips to OpenAI, potentially bringing in tens of billions in annual revenue. OpenAI also received warrants to buy up to 10% of AMD’s stock at a nominal price.
6 October 2025
··
Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle’s $300B AI Cloud Gamble – Can ORCL Stock Become the Next $1 Trillion Tech Titan?

Oracle shares surged 36% in one day after its September earnings report showed a record jump in cloud contract bookings, with the stock up about 70% year-to-date at $285 as of early October. The company landed a $300 billion, five-year cloud deal with OpenAI and is negotiating a $20 billion-plus contract with Meta. Oracle’s cloud backlog hit $455 billion, up 359% year-over-year. Long-term debt now exceeds $100 billion after heavy spending and bond issuance.
6 October 2025
·····
1 … 1,285 1,286 1,287 1,288 1,289 … 1,323
Go toTop